Versani - Effective, Creative and Sustainable Solutions.

Effective, Creative
and Sustainable Solutions.

A consulting firm specializing in the life sciences industry and healthcare sector.

At Versani Health Consulting, we are experts in offering strategic solutions for the Life Sciences industry and the Healthcare sector. We are by your side in a solid partnership, focused on achieving consistent and impactful results.

We understand the complexity and constant transformations of this crucial sector. That’s why we work collaboratively, immersed in the context and needs of our clients, to develop customized, creative and sustainable solutions. Our commitment is to transform these solutions into successful long-term strategies.

We operate with a focus on concrete results, based on rigorous ethical practices and full compliance with the best compliance policies, ensuring that our actions always reflect integrity and

Our Solutions

Specialized Consulting in Business Strategies:

Choosing the right approach to the healthcare market and the most perfect business model is essential for the introduction, growth and development of the business in a sustainable way.

Launch of new Health Technologies:

Including preparation of product dossiers for submission to ANVISA; CMED; CONITEC and ANS: Understanding regulatory requirements, pricing and coverage/reimbursement processes and power dynamics is essential for accessing health resources in the complex business environment of the Brazilian pharmaceutical and medical device sector.

Market access:

Knowledge of the patient journey and the power dynamics of the many different business segments in the sector are critical to accessing healthcare resources in the complex business environment of the Brazilian pharmaceutical and medical device sector.

Product Positioning:

The precise positioning of products and services is essential to achieving business objectives and making the most of their potential, in addition to being a critical variable in a sustainable business strategy.

Go-To-Market / Distribution / Partnership Models:

Choosing the best format to approach such a complex and dynamic market is certainly a decisive factor for business growth and development. Identifying and selecting the model that best suits the specific characteristics of a business can make all the difference for a healthcare business.

Customers Served

Our Team

Versani Health Consulting is led by two highly experienced professionals who, throughout their extensive careers, have led businesses in Brazil and other Latin American countries for the most important and respected pharmaceutical companies in the world:

Maurício Quintas Grimoni

Economist with an MBA in Administration and Economics of Healthcare Organizations from PUC-São Paulo. Mauricio developed his career over 28 years in major pharmaceutical and medical device industries, such as; Bristol Myers Squibb, Merck Serono, Novartis, Janssen and Becton Dickinson, always in leadership positions in Latin America, where he successfully executed his core competencies: development and implementation of successful and sustainable business strategies, based on legal and ethical foundations and in accordance with corporate compliance policies.

Since 2012, as founder and senior consultant at Latina Health Solutions and since 2018, as founder and senior consultant at Versani Health Consulting, he has led consulting projects for important pharmaceutical and consulting companies specialized in the Life Sciences industry and the Healthcare Sector in Brazil and other Latin American countries.

Orlando Vitor Silva

Master in People Management from Mackenzie, Industrial Chemistry from the Faculty of Sciences of São Bernardo do Campo, Post-Graduate in International Marketing from UNIP and Business Administration from the Faculty of Economics São Luis, before becoming a consultant in March 2023, Orlando worked for 47 years in multinational industries.

He began his career in 1976 at the American company West Pharmaceutical Services, leaving the company in 1996 as Industrial Manager. Between 1996 and 2006, he worked at the Swiss pharmaceutical company Serono, a leading pharmaceutical company in the development of biological and biotechnological medicines for Human Reproduction and Multiple Sclerosis, where he held the position of Corporate Director until the company was incorporated by the German company Merck. At Merck, he worked directly in the merger of the two companies, supporting the creation of the Merck Serono unit, with responsibilities as Regulatory, Corporate and Access Director.

From 2013 to 2023 he worked as an executive at Eli Lilly do Brasil, leaving the company in March 2023 as Associate Vice President of Corporate Affairs, responsible for Regulatory, Market Access, Government Relations and Communication.

Until 2020, he served as an ad-hoc member of Anvisa on the review committee of the Brazilian Pharmacopoeia of Biological Products, and since 2004 he has been a Professor in the Postgraduate Program at Faculdade Oswaldo Cruz, in the chair of Registration of Biological/Biotechnological Products.